252 related articles for article (PubMed ID: 32850352)
1. Long-Term Survival Analysis of Transarterial Chemoembolization Plus Radiotherapy vs. Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion.
Su TS; Li LQ; Meng WW; Wang YD; Chen YT; Li JX; Du YQ; Qu S; Zhao C; Huang DJ; Liang SX; Li LQ
Front Oncol; 2020; 10():1205. PubMed ID: 32850352
[No Abstract] [Full Text] [Related]
2. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
3. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization Plus Radiotherapy Versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis.
Chu HH; Kim JH; Shim JH; Yoon SM; Kim PH; Alrashidi I
Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32365655
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib Combined with Chemoembolization for Locally Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score Analysis.
Kim GH; Choi SL; Kim JH; Shim JH; Alali M; Kim N
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685437
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial.
Yoon SM; Ryoo BY; Lee SJ; Kim JH; Shin JH; An JH; Lee HC; Lim YS
JAMA Oncol; 2018 May; 4(5):661-669. PubMed ID: 29543938
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiation Therapy vs. Transarterial Chemoembolization in Inoperable Barcelona Clinic Liver Cancer Stage a Hepatocellular Carcinoma: A Retrospective, Propensity-Matched Analysis.
Su TS; Liang P; Zhou Y; Huang Y; Cheng T; Qu S; Chen L; Xiang BD; Zhao C; Huang DJ; Liang SX; Li LQ
Front Oncol; 2020; 10():347. PubMed ID: 32266136
[No Abstract] [Full Text] [Related]
8. Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.
Liu S; Li H; Guo L; Zhang B; Zhou B; Zhang W; Zhou J; Fan J; Ye Q
Oncologist; 2019 Apr; 24(4):513-520. PubMed ID: 30552155
[TBL] [Abstract][Full Text] [Related]
9. Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C.
Kim YJ; Jung J; Joo JH; Kim SY; Kim JH; Lim YS; Lee HC; Kim JH; Yoon SM
Radiother Oncol; 2019 Dec; 141():95-100. PubMed ID: 31506181
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma.
Allignet B; Pradat P; Mornex F; Izarn F; Rode A; Mabrut JY; Mohkam K; Merle P
Strahlenther Onkol; 2023 Mar; 199(3):293-303. PubMed ID: 36441171
[TBL] [Abstract][Full Text] [Related]
11. Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and Radiotherapy.
Jung J; Joo JH; Kim SY; Kim JH; Choi J; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Park JH; Yoon SM
Liver Cancer; 2022 Apr; 11(2):152-161. PubMed ID: 35634423
[TBL] [Abstract][Full Text] [Related]
12. Beneficial Effect of Combining Radiotherapy and Transarterial Chemoembolization on Patient Survival in Hepatocellular Carcinomas and Macrovascular Invasion Treated with Sorafenib.
Lu MC; Huang WY; Fan HL; Chen TW; Chang WC; Lin HH; Shih YL; Hsieh TY; Huang WC
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345023
[TBL] [Abstract][Full Text] [Related]
13. Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis.
Wong TC; Chiang CL; Lee AS; Lee VH; Yeung CS; Ho CH; Cheung TT; Ng KK; Chok SH; Chan AC; Dai WC; Wong FC; Luk MY; Leung TW; Lo CM
Surg Oncol; 2019 Mar; 28():228-235. PubMed ID: 30851906
[TBL] [Abstract][Full Text] [Related]
14. Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.
Lee D; Lee HC; An J; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
Clin Mol Hepatol; 2018 Jun; 24(2):144-150. PubMed ID: 29665630
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Efficacy and Safety of Transarterial Chemoembolization with or without Lenvatinib for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score-Matched Analysis.
Chen YX; Zhang JX; Zhou CG; Liu J; Liu S; Shi HB; Zu QQ
J Hepatocell Carcinoma; 2022; 9():685-694. PubMed ID: 35937909
[TBL] [Abstract][Full Text] [Related]
17. Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.
Wang L; Chen B; Li Z; Yao X; Liu M; Rong W; Wu F; Lin S; Liu Y; Zheng Y; Li Y; Wang W; Wu J
Onco Targets Ther; 2019; 12():1237-1247. PubMed ID: 30863091
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization (TACE) combined with apatinib versus TACE combined with sorafenib in advanced hepatocellular carcinoma patients: a multicenter retrospective study.
Qiu Z; Shen L; Jiang Y; Qiu J; Xu Z; Shi M; Yu Z; Ma Y; He W; Zheng Y; Li B; Wang G; Yuan Y
Ann Transl Med; 2021 Feb; 9(4):283. PubMed ID: 33708910
[TBL] [Abstract][Full Text] [Related]
19. Should transarterial chemoembolization be given before or after intensity-modulated radiotherapy to treat patients with hepatocellular carcinoma with portal vein tumor thrombus? a propensity score matching study.
Li X; Guo W; Guo L; Lau WY; Ge N; Wang K; Cheng S
Oncotarget; 2018 May; 9(36):24537-24547. PubMed ID: 29849959
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapy after TACE for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: Stereotactic Body Radiotherapy versus Sorafenib.
Shen L; Xi M; Zhao L; Zhang X; Wang X; Huang Z; Chen Q; Zhang T; Shen J; Liu M; Huang J
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30558224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
